• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

Susan Collins’ Maine concession could leave New England without a Republican in Congress for the first time since the 1850s

2

Billionaire Vivek Ramaswamy’s millions and Greg Abbott’s $106 million war chest couldn’t stop Democrats from flipping Texas and Ohio

3

James Talarico was a 23-year-old middle school teacher when an 11-year-old inspired him to run for office—now he's making history in Texas as Senator

1

Susan Collins’ Maine concession could leave New England without a Republican in Congress for the first time since the 1850s

2

Billionaire Vivek Ramaswamy’s millions and Greg Abbott’s $106 million war chest couldn’t stop Democrats from flipping Texas and Ohio

3

James Talarico was a 23-year-old middle school teacher when an 11-year-old inspired him to run for office—now he's making history in Texas as Senator

Venture capital deals

By
Dan Primack
Dan Primack
Down Arrow Button Icon
By
Dan Primack
Dan Primack
Down Arrow Button Icon
September 6, 2012, 2:59 PM ET
Google source logo
Add Fortune on Google for similar content.

BioMotiv, a Cleveland-based, has raised $21 million in Series A funding. Backers include University Hospitals Health System Inc. and the Harrington family. www.biomotiv.com

Bigcommerce, an Austin, Texas-based e-commerce platform for SMBs, has raised $20 million in Series B funding. General Catalyst Partners led the round, and was joined by Floodgate.www.bigcommerce.com

Doximity, a San Francisco-based professional network for physicians, has raised $17 million in Series B funding. Morgenthaler Ventures led the round, and was joined by return backers Emergence Capital Partners and InterWest Partners. The company previously raised $10 million. www.doximity.com

Act-On Software, a Beaverton, Ore.-based provider of cloud-based integrated marketing platforms, has raised $16 million in Series D funding. Norwest Venture Partners led the round, and was joined by return backers Trinity Ventures, US Venture Partners and Voyager Capital also participating. www.act-on.com

Zymeworks
, a Vancouver-based developer of bi-specific antibody therapeutics and multi-valent protein therapeutics, has raised C$11 million in VC funding led by Advanced Biotechnologies Venture Fund.www.zymeworks.com

Sign up for Dan’s daily email newsletter on deals and deal-makers: GetTermSheet.com

About the Author
By Dan Primack
See full bioRight Arrow Button Icon

Latest in


Most Popular

Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    Recommended For You

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.